BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 3553437)

  • 1. Prolongation of survival for high-grade malignant gliomas with adjuvant high-dose BCNU and autologous bone marrow transplantation.
    Johnson DB; Thompson JM; Corwin JA; Mosley KR; Smith MT; de los Reyes RA; Daly MB; Petty AM; Lamaster D; Pierson WP
    J Clin Oncol; 1987 May; 5(5):783-9. PubMed ID: 3553437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients.
    Durando X; Lemaire JJ; Tortochaux J; Van-Praagh I; Kwiatkowski F; Vincent C; Bailly C; Verrelle P; Irthum B; Chazal J; Bay JO
    Bone Marrow Transplant; 2003 Apr; 31(7):559-64. PubMed ID: 12692621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas.
    Rajkumar SV; Buckner JC; Schomberg PJ; Pitot HC; Ingle JN; Cascino TL
    Neurosurgery; 1999 Jan; 44(1):67-73. PubMed ID: 9894965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose BCNU and autologous progenitor cell transplantation given with intra-arterial cisplatinum and simultaneous radiotherapy in the treatment of high-grade gliomas: benefit for selected patients.
    Fernández-Hidalgo OA; Vanaclocha V; Vieitez JM; Aristu JJ; Rebollo J; Gúrpide A; Aramendía JM; Moreno-Palanques R; Martín-Algarra S; Subirá ML; Brugarolas A
    Bone Marrow Transplant; 1996 Jul; 18(1):143-9. PubMed ID: 8832007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I evaluation of radiation combined with recombinant interferon alpha-2a and BCNU for patients with high-grade glioma.
    Rajkumar SV; Buckner JC; Schomberg PJ; Cascino TL; Burch PA; Dinapoli RP
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):297-302. PubMed ID: 9457812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloablative chemotherapy with autologous bone marrow rescue in young children with recurrent malignant brain tumors.
    Guruangan S; Dunkel IJ; Goldman S; Garvin JH; Rosenblum M; Boyett JM; Gardner S; Merchant TE; Gollamudi S; Finlay JL
    J Clin Oncol; 1998 Jul; 16(7):2486-93. PubMed ID: 9667268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: phase I trial.
    Brem H; Ewend MG; Piantadosi S; Greenhoot J; Burger PC; Sisti M
    J Neurooncol; 1995 Nov; 26(2):111-23. PubMed ID: 8787853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose carmustine for high-grade gliomas in childhood.
    Bouffet E; Khelfaoui F; Philip I; Biron P; Brunat-Mentigny M; Philip T
    Cancer Chemother Pharmacol; 1997; 39(4):376-9. PubMed ID: 9025780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) monochemotherapy and autologous marrow transplantation for malignant glioma.
    Phillips GL; Wolff SN; Fay JW; Herzig RH; Lazarus HM; Schold C; Herzig GP
    J Clin Oncol; 1986 May; 4(5):639-45. PubMed ID: 3009725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous bone-marrow transplantation: host effects of high-dose BCNU.
    Takvorian T; Parker LM; Hochberg FH; Canellos GP
    J Clin Oncol; 1983 Oct; 1(10):610-20. PubMed ID: 6366127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II study.
    Phillips GL; Fay JW; Herzig GP; Herzig RH; Weiner RS; Wolff SN; Lazarus HM; Karanes C; Ross WE; Kramer BS
    Cancer; 1983 Nov; 52(10):1792-802. PubMed ID: 6354414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose carmustine with autologous bone marrow transplantation for the adjuvant treatment of high-grade gliomas of the central nervous system.
    Wolff SN; Phillips GL; Herzig GP
    Cancer Treat Rep; 1987 Feb; 71(2):183-5. PubMed ID: 3026626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose chemotherapy and autologous bone marrow rescue followed by interstitial and external-beam radiotherapy in newly diagnosed pediatric malignant gliomas.
    Heideman RL; Douglass EC; Krance RA; Fontanesi J; Langston JA; Sanford RA; Kovnar EH; Ochs J; Kuttesch J; Jenkins JJ
    J Clin Oncol; 1993 Aug; 11(8):1458-65. PubMed ID: 8336185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose BCNU with autologous bone marrow rescue for recurrent glioblastoma multiforme.
    Hochberg FH; Parker LM; Takvorian T; Canellos GP; Zervas NT
    J Neurosurg; 1981 Apr; 54(4):455-60. PubMed ID: 6259300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma.
    Dinapoli RP; Brown LD; Arusell RM; Earle JD; O'Fallon JR; Buckner JC; Scheithauer BW; Krook JE; Tschetter LK; Maier JA
    J Clin Oncol; 1993 Jul; 11(7):1316-21. PubMed ID: 8315428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytoma.
    Mbidde EK; Selby PJ; Perren TJ; Dearnaley DP; Whitton A; Ashley S; Workman P; Bloom HJ; McElwain TJ
    Br J Cancer; 1988 Dec; 58(6):779-82. PubMed ID: 2852028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease.
    Reece DE; Barnett MJ; Connors JM; Fairey RN; Fay JW; Greer JP; Herzig GP; Herzig RH; Klingemann HG; LeMaistre CF
    J Clin Oncol; 1991 Oct; 9(10):1871-9. PubMed ID: 1919637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose BCNU therapy with autologous bone marrow infusion: preliminary observations.
    Spitzer G; Dicke KA; Verma DS; Zander A; McCredie KB
    Cancer Treat Rep; 1979 Aug; 63(8):1257-64. PubMed ID: 383292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of malignant gliomas with high-dose ACNU and autologous bone marrow transplantation].
    Nakagawa H; Murasawa A; Taki T; Nakajima S; Niiyama K; Furuta Y; Nakamura H; Shibata H; Masaoka T
    Gan To Kagaku Ryoho; 1988 Nov; 15(11):3153-7. PubMed ID: 2847660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective comparison of chemoradiotherapy followed by adjuvant chemotherapy, with or without prior gliadel implantation (carmustine) after initial surgery in patients with newly diagnosed high-grade gliomas.
    Noël G; Schott R; Froelich S; Gaub MP; Boyer P; Fischer-Lokou D; Dufour P; Kehrli P; Maitrot D
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):749-55. PubMed ID: 21300471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.